BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $224,000 | +5.2% | 2,657 | 0.0% | 0.01% | +7.7% |
| Q4 2020 | $213,000 | -0.5% | 2,657 | 0.0% | 0.01% | -13.3% |
| Q3 2020 | $214,000 | -7.0% | 2,657 | -2.6% | 0.02% | -11.8% |
| Q2 2020 | $230,000 | +6.5% | 2,728 | +2.4% | 0.02% | -5.6% |
| Q1 2020 | $216,000 | -40.2% | 2,664 | -38.3% | 0.02% | -21.7% |
| Q4 2019 | $361,000 | -15.3% | 4,320 | -11.3% | 0.02% | -23.3% |
| Q3 2019 | $426,000 | +6.0% | 4,873 | -0.6% | 0.03% | +7.1% |
| Q2 2019 | $402,000 | +12.3% | 4,903 | +11.3% | 0.03% | +12.0% |
| Q1 2019 | $358,000 | +36.6% | 4,405 | +10.6% | 0.02% | +31.6% |
| Q4 2018 | $262,000 | -60.6% | 3,983 | -57.3% | 0.02% | -52.5% |
| Q3 2018 | $665,000 | -10.7% | 9,329 | -7.6% | 0.04% | -14.9% |
| Q2 2018 | $745,000 | +11.9% | 10,096 | -1.4% | 0.05% | +17.5% |
| Q1 2018 | $666,000 | +0.5% | 10,241 | -0.2% | 0.04% | +5.3% |
| Q4 2017 | $663,000 | -7.1% | 10,262 | -9.8% | 0.04% | -9.5% |
| Q3 2017 | $714,000 | +8.2% | 11,375 | +3.6% | 0.04% | +23.5% |
| Q2 2017 | $660,000 | +12.4% | 10,976 | -3.1% | 0.03% | +13.3% |
| Q1 2017 | $587,000 | +15.3% | 11,325 | -1.3% | 0.03% | +11.1% |
| Q4 2016 | $509,000 | -25.9% | 11,472 | -20.5% | 0.03% | -20.6% |
| Q3 2016 | $687,000 | +7.0% | 14,423 | +1.6% | 0.03% | +6.2% |
| Q2 2016 | $642,000 | +7.2% | 14,195 | -2.6% | 0.03% | +10.3% |
| Q1 2016 | $599,000 | +9.5% | 14,573 | +1.6% | 0.03% | +11.5% |
| Q4 2015 | $547,000 | -6.7% | 14,347 | -19.5% | 0.03% | -13.3% |
| Q3 2015 | $586,000 | -77.9% | 17,824 | -53.0% | 0.03% | -75.0% |
| Q2 2015 | $2,650,000 | -11.7% | 37,892 | -13.5% | 0.12% | -1.6% |
| Q1 2015 | $3,000,000 | -9.6% | 43,802 | -3.2% | 0.12% | -12.9% |
| Q4 2014 | $3,317,000 | +6.0% | 45,255 | +3.8% | 0.14% | +2.9% |
| Q3 2014 | $3,130,000 | -19.1% | 43,614 | -18.5% | 0.14% | -16.6% |
| Q2 2014 | $3,870,000 | -14.0% | 53,533 | -12.5% | 0.16% | -16.8% |
| Q1 2014 | $4,500,000 | +7.5% | 61,154 | +1.6% | 0.20% | +8.3% |
| Q4 2013 | $4,185,000 | -65.6% | 60,167 | -67.5% | 0.18% | -68.5% |
| Q3 2013 | $12,155,000 | -8.2% | 185,029 | -1.7% | 0.57% | -5.1% |
| Q2 2013 | $13,244,000 | – | 188,306 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |